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More education is needed before we burden women
with their HPV status
Emma Damon Butterfield foundation year 2 doctor
Heart of England Foundation Trust, Birmingham B9 5SS, UK
Elfström and colleagues do not discuss the ethics of human
papillomavirus (HPV) testing, which will become a more
contentious problem as more women are screened for HPV.1
We encourage patients diagnosed with sexually transmitted
infections to tell their sexual partners. It is mandatory for
patients to inform their partners of potentially life threatening
infections like HIV: if the patient refuses to do so, the doctor
may break confidentiality to inform the at-risk partner.2
Knowingly exposing someone to HIV infection is a crime in
the UK.3
HPV infection is common—most sexually active adults will be
infected with at least one strain at some point: 39% of 20-24
year old women in the UK have potentially oncogenic HPV
types 16 or 18.4
Except for strains that cause genital warts, most HPV infections
are initially asymptomatic: currently most HPV infected women
are blissfully ignorant of their status. If widespread HPV testing
is rolled out, how will we advise women to talk to their sexual
partners about their HPV status? Sexually transmitted infections
are still a difficult topic to discuss: especially if the infection is
untreatable.
Will we ask women to tell partners that they are infected with
an untreatable infection? Or say that they need to tell their
partners only about oncogenic strains and strains that cause
warts? There might be legal ramifications for a woman who
knowingly transmits HPV to a male partner, who subsequently
infects another female, who develops cervical cancer.
We need to arm patients with the facts, so that they can have a
meaningful conversation about HPV with their partners. If we
are going to tell women their HPV status, we should support
their ability to cope with that information.
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